paroxetine has been researched along with Delusional Disorder in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hayashi, H; Ishikawa, J; Kawakatsu, S; Oshino, S; Otani, K | 1 |
| Knopf, U; Kuwilsky, A; Zink, M | 1 |
2 other study(ies) available for paroxetine and Delusional Disorder
| Article | Year |
|---|---|
Paroxetine treatment of delusional disorder, somatic type.
Topics: Aged; Antidepressive Agents, Second-Generation; Female; Humans; Parietal Lobe; Paroxetine; Schizophrenia, Paranoid; Temporal Lobe; Tomography, Emission-Computed, Single-Photon | 2004 |
Management of clozapine-induced obsessive-compulsive symptoms in a man with schizophrenia.
Topics: Adult; Anti-Anxiety Agents; Antipsychotic Agents; Aripiprazole; Clozapine; Dose-Response Relationship, Drug; Drug Therapy, Combination; Humans; Male; Obsessive-Compulsive Disorder; Paroxetine; Piperazines; Psychiatric Status Rating Scales; Quinolones; Schizophrenia, Paranoid | 2007 |